Clinical trial · Observational
The Roles of Tissue Factor in Malignant Gliomas
NCT00201903CI-TRIAL-00026831completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To explore the relationship between tissue factor levels, tumour progression, activation of blood coagulation and venous thromboembolism with malignant glioma
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Brain Tumors | Brain Neoplasm | ALIAS | 0.90 |
| Venous Thromboembolism | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * participation in PRODIGE * adult patients * newly diagnosed, biopsy-confirmed grade III/IV malignant gliomas * undergone craniotomy or stereotactic biopsy \> 2 days and \< 4 weeks before Exclusion Criteria: * have known hereditary thrombophilia * are receiving experimental antiangiogenic therapy
References
Publications (0)
Data not yet available
No reference posted for this study.